EPZM

Epizyme, Inc. News Headlines

$21.59
*  
0.90
4.35%
Get EPZM Alerts
*Delayed - data as of Jan. 27, 2015  -  Find a broker to begin trading EPZM now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    EPZM Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Epizyme: Undervalued Rare Asset With Outsized Potential
6/20/2014 7:30:00 AM - Seeking Alpha


Today In SA PRO: Thursday, June 19
6/20/2014 5:00:00 AM - Seeking Alpha


Biotech Stocks Get Turbo Boost From Idenix Deal
6/11/2014 6:45:00 PM - Seeking Alpha


Cramer's Lightning Round - Brunswick Lowers The Bar (4/25/14)
4/27/2014 6:29:00 AM - Seeking Alpha


Epizyme Up on Milestone Payment from Glaxo - Analyst Blog
4/23/2014 6:10:01 PM - Zacks.com


Biotech Boomlet Set To Smash IPO Record For Two-Week Period
2/2/2014 5:42:00 AM - Seeking Alpha


Cellceutix Is Significantly Undervalued Considering The Value Of Brilacidin
1/28/2014 9:31:00 AM - Seeking Alpha


Is The Healthcare Sector Pulling Back Or Crashing?
1/28/2014 5:40:00 AM - Seeking Alpha


Epizyme Up on Milestone Payments - Analyst Blog
1/8/2014 12:10:01 PM - Zacks.com


Biotech Stock Roundup: Amgen Data Looks Good, CANF Tumbles - Industry Outlook
1/8/2014 10:17:00 AM - Investopedia


Cramer's Mad Money - My New Year's Resolution For Investing (1/7/14)
1/8/2014 5:40:00 AM - Seeking Alpha


Epizyme: Exciting Science, Exciting Investment Opportunity
12/19/2013 12:41:00 PM - Seeking Alpha


Epizyme: The Promise Of Personalized Cancer Therapy
9/15/2013 8:21:00 PM - Seeking Alpha


Scientific Conferences Create Buzz And Move Biotech Stocks: Michael King
9/6/2013 11:24:00 AM - Seeking Alpha


Epizyme Wins Orphan Drug Status - Analyst Blog
8/22/2013 10:30:01 AM - Zacks.com


New Cancer Targets And Big Partnerships May Be Driving Huge Epizyme Valuation
8/21/2013 12:44:00 PM - Seeking Alpha


Cramer's Lightning Round - How Much Do I Like Kroger? (8/20/13)
8/21/2013 6:31:00 AM - Seeking Alpha


Epizyme Gets Orphan Drug Designation On Leukemia Drug
8/20/2013 1:43:00 PM - Seeking Alpha


Epizyme Continues To Shine
7/16/2013 1:52:00 PM - Seeking Alpha


Cramer's Mad Money - 19 Things To Watch In The Week Ahead (7/12/13)
7/14/2013 5:13:00 AM - Seeking Alpha


In Insider Trading, Biopharma Companies Synta Pharmaceuticals and Epizyme See Purchases
6/7/2013 11:35:00 AM - Minyanville


Epizyme Up Big After IPO - Impressive Pipeline
6/4/2013 2:52:00 PM - Seeking Alpha


Epizyme - Investors Are Wildly Enthusiastic About Future Prospects Of This Recent IPO
6/4/2013 6:14:00 AM - Seeking Alpha


Company News for June 3, 2013 - Corporate Summary
6/3/2013 9:33:14 AM - Zacks.com


4 US IPOs planned for the week of Jun 3
6/3/2013 7:00:04 AM - Renaissance Capital